MCM
MDXG icon

Matarin Capital Management’s MiMedx Group MDXG Stock Holding History

Matarin Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-694,135
Closed -$8.25M – 301
2017
Q3 		$8.25M Buy
+694,135
New +$10.3M 0.7% 48

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Matarin Capital Management's MDXG Position: Q4 2017 in Review

Matarin Capital Management sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 694,135 shares — an estimated $8.25M sold.

Matarin Capital Management first reported a position in MDXG in Q3 2017 and held it in 1 quarter. The position peaked at $8.25M in Q3 2017. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

  • Matarin Capital Management reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
  • Matarin Capital Management sold 694,135 MiMedx Group shares in Q4 2017, an estimated $8.25M.
  • Matarin Capital Management first reported a position in MiMedx Group in Q3 2017 and held it in 1 quarter.
  • Matarin Capital Management's MiMedx Group position peaked at $8.25M in Q3 2017.
  • 236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on Matarin Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.